• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Necessity under construction - societal weighing rationality in the appraisal of health care technologies.必要性的构建——社会在医疗技术评估中的权衡理性。
Health Econ Policy Law. 2021 Oct;16(4):457-472. doi: 10.1017/S1744133120000341. Epub 2020 Sep 21.
2
The bare necessities? A realist review of necessity argumentations used in health care coverage decisions.必需品?卫生保健覆盖决策中使用的必要性论证的现实主义综述。
Health Policy. 2017 Jul;121(7):731-744. doi: 10.1016/j.healthpol.2017.04.011. Epub 2017 May 5.
3
The use of economic evaluations in NHS decision-making: a review and empirical investigation.国民健康服务体系决策中经济评估的应用:一项综述与实证研究
Health Technol Assess. 2008 Apr;12(7):iii, ix-x, 1-175. doi: 10.3310/hta12070.
4
Under careful construction: combining findings, arguments, and values into robust health care coverage decisions.精心构建:将发现、论点和价值观结合起来,做出稳健的医疗保健覆盖决策。
BMC Health Serv Res. 2022 Jun 7;22(1):756. doi: 10.1186/s12913-022-07781-1.
5
Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience.用于卫生技术评估的多标准决策分析(MCDA):昆士兰卫生部门的经验
Aust Health Rev. 2019 Oct;43(5):591-599. doi: 10.1071/AH18042.
6
Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development.为 NICE 何时应仅在适当设计的证据开发计划背景下推荐使用卫生技术制定决策框架提供信息。
Health Technol Assess. 2012;16(46):1-323. doi: 10.3310/hta16460.
7
Decision-makers' preferences for approving new medicines in Wales: a discrete-choice experiment with assessment of external validity.决策者对威尔士批准新药的偏好:一项具有外部有效性评估的离散选择实验。
Pharmacoeconomics. 2013 Apr;31(4):345-55. doi: 10.1007/s40273-013-0030-0.
8
Decision making in NICE single technological appraisals: How does NICE incorporate patient perspectives?NICE 单技术评估中的决策制定:NICE 如何纳入患者观点?
Health Expect. 2018 Feb;21(1):128-137. doi: 10.1111/hex.12594. Epub 2017 Jul 7.
9
How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.成本效益分析应如何用于卫生技术覆盖决策?来自英国国家卫生与临床优化研究所方法的证据。
J Health Serv Res Policy. 2007 Apr;12(2):73-9. doi: 10.1258/135581907780279521.
10
Around the Tables - Contextual Factors in Healthcare Coverage Decisions Across Western Europe.圆桌会议 - 西欧医疗保健覆盖决策中的背景因素。
Int J Health Policy Manag. 2020 Sep 1;9(9):390-402. doi: 10.15171/ijhpm.2019.145.

引用本文的文献

1
A HTA of what? Reframing through including patient perspectives in health technology assessment processes.一项什么样的 HTA?通过纳入患者视角重新构建卫生技术评估流程。
Int J Technol Assess Health Care. 2023 May 18;39(1):e27. doi: 10.1017/S0266462323000132.
2
Social pharmaceutical innovation and alternative forms of research, development and deployment for drugs for rare diseases.社会制药创新与罕见病药物的研发和部署的替代形式。
Orphanet J Rare Dis. 2022 Sep 5;17(1):344. doi: 10.1186/s13023-022-02476-6.
3
Under careful construction: combining findings, arguments, and values into robust health care coverage decisions.精心构建:将发现、论点和价值观结合起来,做出稳健的医疗保健覆盖决策。
BMC Health Serv Res. 2022 Jun 7;22(1):756. doi: 10.1186/s12913-022-07781-1.

本文引用的文献

1
Around the Tables - Contextual Factors in Healthcare Coverage Decisions Across Western Europe.圆桌会议 - 西欧医疗保健覆盖决策中的背景因素。
Int J Health Policy Manag. 2020 Sep 1;9(9):390-402. doi: 10.15171/ijhpm.2019.145.
2
Equity Weights for Priority Setting in Healthcare: Severity, Age, or Both?医疗保健中优先排序的权益权重:严重程度、年龄还是两者兼有?
Value Health. 2019 Dec;22(12):1441-1449. doi: 10.1016/j.jval.2019.07.012. Epub 2019 Sep 7.
3
Looking back and moving forward: On the application of proportional shortfall in healthcare priority setting in the Netherlands.回顾与展望:荷兰医疗卫生优先事项配置中应用比例不足的情况。
Health Policy. 2018 Jun;122(6):621-629. doi: 10.1016/j.healthpol.2018.04.001. Epub 2018 Apr 7.
4
Decision making in NICE single technological appraisals: How does NICE incorporate patient perspectives?NICE 单技术评估中的决策制定:NICE 如何纳入患者观点?
Health Expect. 2018 Feb;21(1):128-137. doi: 10.1111/hex.12594. Epub 2017 Jul 7.
5
The bare necessities? A realist review of necessity argumentations used in health care coverage decisions.必需品?卫生保健覆盖决策中使用的必要性论证的现实主义综述。
Health Policy. 2017 Jul;121(7):731-744. doi: 10.1016/j.healthpol.2017.04.011. Epub 2017 May 5.
6
Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies.卫生技术评估(HTA)中真实世界数据的使用政策:六个HTA机构的比较研究
Value Health. 2017 Apr;20(4):520-532. doi: 10.1016/j.jval.2016.12.003. Epub 2017 Jan 27.
7
Still Elegantly Muddling Through? NICE and Uncertainty in Decision Making About the Rationing of Expensive Medicines in England.仍在优雅地敷衍了事?英国昂贵药品配给决策中的国家卫生与临床优化研究所及不确定性
Int J Health Serv. 2017 Jul;47(3):571-594. doi: 10.1177/0020731416689552. Epub 2017 Jan 23.
8
Fair Processes for Priority Setting: Putting Theory into Practice Comment on "Expanded HTA: Enhancing Fairness and Legitimacy".公平的优先级设定流程:将理论付诸实践——评《扩大 HTA:增强公平性和合法性》
Int J Health Policy Manag. 2017 Jan 1;6(1):43-47. doi: 10.15171/ijhpm.2016.85.
9
Contested evidence: a Dutch reimbursement decision taken to court.有争议的证据:一项荷兰报销决定被诉诸法庭。
Health Econ Policy Law. 2017 Jul;12(3):325-344. doi: 10.1017/S1744133116000281. Epub 2016 Nov 15.
10
A comparative study of drug listing recommendations and the decision-making process in Australia, the Netherlands, Sweden, and the UK.澳大利亚、荷兰、瑞典和英国药品上市推荐及决策过程的比较研究
Health Policy. 2016 Oct;120(10):1104-1114. doi: 10.1016/j.healthpol.2016.08.006. Epub 2016 Aug 31.

必要性的构建——社会在医疗技术评估中的权衡理性。

Necessity under construction - societal weighing rationality in the appraisal of health care technologies.

机构信息

Erasmus School of Health Policy & Management, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, the Netherlands.

出版信息

Health Econ Policy Law. 2021 Oct;16(4):457-472. doi: 10.1017/S1744133120000341. Epub 2020 Sep 21.

DOI:10.1017/S1744133120000341
PMID:32955010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8460450/
Abstract

Health care coverage decisions may employ many different considerations, which are brought together across two phases. The assessment phase examines the available scientific evidence, such as the cost-effectiveness, of the technology. The appraisal then contextualises this evidence to arrive at an (advised) coverage decision, but little is known about how this is done.In the Netherlands, the appraisal is set up to achieve a societal weighing and is the primary place where need- and solidarity-related ('necessity') argumentations are used. To elucidate how the Dutch appraisal committee 'constructs necessity', we analysed observations and recordings of two appraisal committee meetings at the National Health Care Institute, the corresponding documents (five), and interviews with committee members and policy makers (13 interviewees in 12 interviews), with attention to specific necessity argumentations.The Dutch appraisal committee constructs necessity in four phases: (1) allowing explicit criteria to steer the process; (2) allowing patient (representative) contributions to challenge the process; (3) bringing new argumentations in from outside and weaving them together; and (4) formulating recommendations to societal stakeholders. We argue that in these ways, the appraisal committee achieves societal weighing rationality, as the committee actively uses argumentations from society and embeds the decision outcome in society.

摘要

医疗保健覆盖决策可能会考虑许多不同的因素,这些因素在两个阶段中结合在一起。评估阶段会考察技术的可用科学证据,如成本效益。然后评估会将这些证据置于特定背景下,以做出(建议的)覆盖决策,但对于如何进行评估知之甚少。在荷兰,评估旨在实现社会权衡,是使用与需求和团结相关(“必要性”)论证的主要场所。为了阐明荷兰评估委员会如何“构建必要性”,我们分析了荷兰国家卫生保健研究所两次评估委员会会议的观察结果和记录、相应的文件(五份)以及对委员会成员和政策制定者的访谈(十二次访谈中有十三位受访者),重点关注特定的必要性论证。荷兰评估委员会通过四个阶段构建必要性:(1)允许明确的标准来引导流程;(2)允许患者(代表)提出意见来挑战流程;(3)从外部引入新的论证并将其融合在一起;(4)向社会利益相关者提出建议。我们认为,通过这些方式,评估委员会实现了社会权衡的合理性,因为委员会积极利用社会的论证,并将决策结果融入社会。